These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 6253242

  • 1. The renin system and future trends in management of high blood pressure.
    Laragh JH.
    Clin Exp Hypertens (1978); 1980; 2(3-4):525-52. PubMed ID: 6253242
    [Abstract] [Full Text] [Related]

  • 2. Renin profiling for diagnosis and treatment of hypertension.
    Laragh JH, Letcher RL, Pickering TG.
    JAMA; 1979 Jan 12; 241(2):151-6. PubMed ID: 31492
    [Abstract] [Full Text] [Related]

  • 3. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH, Case DB, Wallace JM, Keim H.
    Fed Proc; 1977 Apr 12; 36(5):1781-7. PubMed ID: 191300
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Issues, goals, and guidelines in selecting first-line drug therapy for hypertension.
    Laragh JH.
    Hypertension; 1989 May 12; 13(5 Suppl):I103-12. PubMed ID: 2490815
    [Abstract] [Full Text] [Related]

  • 6. Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol.
    Laragh JH.
    Am J Med; 1976 Nov 12; 61(5):797-810. PubMed ID: 10730
    [Abstract] [Full Text] [Related]

  • 7. The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension.
    Laragh JH, Sealey JE, Bühler FR, Vaughan ED, Brunner HR, Gavras H, Baer L.
    Am J Med; 1975 Jan 12; 58(1):4-13. PubMed ID: 234677
    [Abstract] [Full Text] [Related]

  • 8. When is it useful to inhibit the renin-angiotensin system for treating hypertension?
    Laragh JH.
    J Cardiovasc Pharmacol; 1985 Jan 12; 7 Suppl 4():S86-91. PubMed ID: 2412020
    [Abstract] [Full Text] [Related]

  • 9. Renin system activity as a determinant of response to treatment in hypertension and heart failure.
    Cody RJ, Laragh JH, Case DB, Atlas SA.
    Hypertension; 1983 Jan 12; 5(5 Pt 2):III36-42. PubMed ID: 6354936
    [Abstract] [Full Text] [Related]

  • 10. The renin system for understanding human hypertension: evidence for blood pressure control by a bipolar vasoconstriction-volume mechanism. Prorenin as a determinant of renin secretion.
    Laragh JH, Sealey JE, Atlas SA.
    Clin Exp Hypertens A; 1982 Jan 12; 4(11-12):2303-37. PubMed ID: 6756698
    [Abstract] [Full Text] [Related]

  • 11. Clinical evaluation and differential diagnosis of the individual hypertensive patient.
    Mueller FB, Laragh JH.
    Clin Chem; 1991 Oct 12; 37(10 Pt 2):1868-79. PubMed ID: 1914203
    [Abstract] [Full Text] [Related]

  • 12. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES, Fernandes LAB, Giollo-Júnior LT, Uyemura JRR, Matarucco CSS, Landim MIP, Cosenso-Martin LN, Tácito LHB, Moreno H, Vilela-Martin JF, Yugar-Toledo JC.
    Trials; 2018 Feb 12; 19(1):101. PubMed ID: 29433578
    [Abstract] [Full Text] [Related]

  • 13. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB, Laragh JH.
    Ann Intern Med; 1979 Aug 12; 91(2):153-60. PubMed ID: 464461
    [Abstract] [Full Text] [Related]

  • 14. Renin-aldosterone profiling in hypertension.
    Mitchell JR, Taylor AA, Pool JL, Lake CR, Rollins DE, Bartter FC.
    Ann Intern Med; 1977 Nov 12; 87(5):596-312. PubMed ID: 335942
    [Abstract] [Full Text] [Related]

  • 15. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JI, White RP, Sealey JE, Laragh JH.
    Am J Med; 1976 Nov 12; 61(5):790-6. PubMed ID: 185903
    [Abstract] [Full Text] [Related]

  • 16. Renin-angiotensin-aldosterone system.
    Dillon MJ.
    Eur J Clin Pharmacol; 1980 Jul 12; 18(1):105-8. PubMed ID: 6249611
    [Abstract] [Full Text] [Related]

  • 17. Drug interactions with saralasin.
    Mitchell HC, Keeton TK, Pettinger WA.
    Kidney Int Suppl; 1979 Mar 12; (9):S101-6. PubMed ID: 289859
    [Abstract] [Full Text] [Related]

  • 18. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
    Pagny JY, Thibonnier M, Corvol P, Menard J.
    J Cardiovasc Pharmacol; 1985 Mar 12; 7 Suppl 4():S82-5. PubMed ID: 2412019
    [Abstract] [Full Text] [Related]

  • 19. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI.
    Br Heart J; 1980 Sep 12; 44(3):290-6. PubMed ID: 7000102
    [Abstract] [Full Text] [Related]

  • 20. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
    Vaughan EF, Laragh JH.
    Urol Clin North Am; 1975 Jun 12; 2(2):237-57. PubMed ID: 1098253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.